Yifeng Yuan

Public M&A

• Represented Blueprint Medicines Corporation in its acquisition by Sanofi for $9.5 billion including contingent value rights
• Represented Ikena Oncology, Inc. (“IKNA”) in its merger with Inmagene Biopharmaceuticals
• Represented Zuora, Inc. (“ZUO”) in its $1.7 billion sale to Silver Lake and GIC
• Represented Novo Holdings in its $16.5 billion all-cash acquisition of Catalent, Inc. (‘CTLT”)
• Represented SailPoint Technologies (“SAIL”) in its $6.9 billion sale to Thoma Bravo
• Represented iRobot Corporation (“IRBT”) in its $1.4 billion sale to Amazon
• Represented Berkshire Grey (‘BGRY”) in its rule 13e-3 sale to the SoftBank Group, valued at approximately $375 million
• Represented eMagin Corporation (‘EMAN”) in its acquisition by Samsung Display Co. in an all-cash transaction valued at approximately $218 million
• Represented Akili Interactive (“AKLI”) in its acquisition through tender offer by Virtual Therapeutics
• Advised Qatalyst Partners in its role as exclusive financial advisor to Alteryx, Inc. (“AYX”)’s acquisition by Clearlake Capital Group, L.P. and Insight Partners in a transaction valued at $4.4 billion
• Represented Aerovate Therapeutics, Inc. in its merger with Jade Biosciences, Inc.
• Represented Gelesis Holdings (“GLS”) in its rule 13e-3 sale to PureTech

Private M&A

• Represented Arthrosi Therapeutics, Inc. in its sale to Sobi for up to $1.5 billion, consisting of an upfront consideration of $950 million, together with up to $550 million in milestone payments
• Represented Cybereason, a SoftBank backed Leading Endpoint Detection and Response (ERD) company, in its proposed acquisition of Trustwave, a cybersecurity and managed security services company
• Represented Axon Communications, Inc., a digital marketing agency, in its sale to Relevate Health, an omnichannel marketing agency
• Represented Kambr, Inc., a revenue management system for airlines, in its sale to Amadeus
• Represented A&M Capital Opportunities’ portfolio company in its acquisition of 12 car wash entities and three add-on acquisitions

De-SPAC

• Representing Freenome Holding, Inc. in its business combination with Perceptive Capital Solutions Corp (“PCSC”) with a post-transaction equity value of approximately $1.1 billion at closing
• Represented TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics) in its business combination with Helix Acquisition Corp. II
• Represented Arrowroot Acquisition Corp. (“ARRW”) of its acquisition of iLearningEngines, Inc., an AI-powered intelligence platform
• Represented Forge Global, Inc. in its business combination with Motive Capital Corp.
• Represented Circle Internet Financial, Inc. in its proposed $9 billion de-SPAC transaction with Concord Acquisition Corp.

Capital Market Offerings

• Advised underwriting syndicate on Lineage’s $5.1 billion initial public offering, the largest REIT IPO in history
• Represented Ocugen, Inc.’s $16.5 million public offering of common stock in a bought offering deal
• Represented TransCode Therapeutics Inc.’s $7 million public offering
• Represented Canaccord Genuity Group Inc. in Blue Apron’s ATM offerings

Company Side

• Engineer.ai Corporation in its Series D financing
• Avenge Bio, Inc. in its Series A financing
• Altan Insights, LLC in its Series Seed financing
• Sentinel BioTherapeutics in its Series Seed financing

Investor Side

• Valar Ventures in its Series A financing of Link Financial
• Left Lane Capital in its Series A financing of Lemonade
• Left Lane Capital in its Series A financing of Perry Health
• Level Equity Management, LLC in its Series A financing of SchoolPass, Inc.
• Greycroft and Acrew in their Series Seed financing of NextData
• LDV Capital in its Series Pre-Seed financing of Burner Page, Inc.